BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6750247)

  • 21. Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: a prospective, randomized trial.
    Sakwa MP; Emery RW; Shannon FL; Altshuler JM; Mitchell D; Zwada D; Holter AR
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):481-5. PubMed ID: 19185173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery.
    Thompson LD; McElhinney DB; Findlay P; Miller-Hance W; Chen MJ; Minami M; Petrossian E; Parry AJ; Reddy VM; Hanley FL
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):220-8. PubMed ID: 11479493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial.
    Leal-Noval SR; Amaya R; Herruzo A; Hernández A; Ordóñez A; Marín-Niebla A; Camacho P
    Ann Thorac Surg; 2005 Oct; 80(4):1394-400. PubMed ID: 16181877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified ultrafiltration: role in adult cardiac surgical haemostasis.
    Zahoor M; Abbass S; Khan AA; Ahmad SA
    J Ayub Med Coll Abbottabad; 2007; 19(4):49-54. PubMed ID: 18693598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin.
    Plachetka JR; Salomon NW; Larson DF; Copeland JG
    Ann Thorac Surg; 1980 Jul; 30(1):58-63. PubMed ID: 6994666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
    Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 32. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass.
    Bennett-Guerrero E; Grocott HP; Levy JH; Stierer KA; Hogue CW; Cheung AT; Newman MF; Carter AA; Rossignol DP; Collard CD
    Anesth Analg; 2007 Feb; 104(2):378-83. PubMed ID: 17242095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study.
    Hessel EA; Johnson DD; Ivey TD; Miller DW
    J Thorac Cardiovasc Surg; 1980 Jul; 80(1):111-22. PubMed ID: 6966720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function.
    Rubens FD; Boodhwani M; Mesana T; Wozny D; Wells G; Nathan HJ;
    Circulation; 2007 Sep; 116(11 Suppl):I89-97. PubMed ID: 17846332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism.
    Morawski W; Sanak M; Cisowski M; Szczeklik M; Szczeklik W; Dropinski J; Waclawczyk T; Ulczok R; Bochenek A
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):791-6. PubMed ID: 16153930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
    Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
    Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.